Subacute necrotizing encephalomyelopathy (Leigh syndrome) in pediatric patients: a retrospective study

Jeng-Dau Tsai; Henry J. Tsai; Sheng-Hui Yang; Ji-Nan Sheu

doi:10.18203/2320-6012.ijrms20151138

Authors

Jeng-Dau Tsai Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, School of Medicine, Chung Shan Medical University, Taichung
Henry J. Tsai Department of Health and Nutrition Biotechnology, Asia University, Taichung
Sheng-Hui Yang Department of Life Sciences, National Chung Hsing University, Taichung
Ji-Nan Sheu Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, School of Medicine, Chung Shan Medical University, Taichung

DOI:

https://doi.org/10.18203/2320-6012.ijrms20151138

Keywords:

Leigh syndrome, Mitochondrial disorder, Lactate, Oral glucose lactate stimulation test, Magnetic resonance spectroscopy

Abstract

Background: The clinical manifestations of Leigh Syndrome (LS) are heterogeneous and its diagnosis is often based on information acquired from multiple levels of inquiry. To identify LS, Oral Glucose Lactate Stimulation Test (OGLST) and Magnetic Resonance Spectroscopy (MRS) have been used as additional tools for evaluation of this metabolic disorder. The objective of the study was to report the clinical manifestations, neuroimaging assessments, and multidisciplinary approaches of lactate in pediatric patients with LS.

Methods: We performed a retrospective charts review of pediatric patients with LS, which underwent the investigations using laboratory tests and Magnetic Resonance Images (MRI)/MRS of the brain.

Results: The distributions of the lesions on the MRI of the brain studies were as the following: basal ganglia (7/8), brainstem (7/8), and cortex (3/8). Despite all of the patients showed disorient neurological manifestations and symmetrical lesions over the basal ganglion and brainstem on MRI, elevated levels of serum lactate were detected in 6 of 8 patients by either random serum sample obtained for lactate or OGLST. Subsequently, the remaining 2 cases were demonstrated with lactate peak over the affected areas by MRS. Cranial MRS showed lactate duplex and decreased N-acetylaspartate/creatine ratio over the affected areas in the 5 of 6 patients.

Conclusions: The study shows the importance of multidisciplinary approaches in the diagnosis of LS. Approach of LS may not only depend on the elevation of the value of random serum lactate but also can be further aided by OGLST or MRS to evaluate metabolic disorder in such patients.

Metrics

Metrics Loading ...

References

Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry. 1951;14:216-21.

Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol. 1993;14:1119-37.

Montpetit VJ, Anderman F, Carpenter S, Fawcett JS, Zborowska-Sluis D, Giberson HR. Subacute necrotizing encephalomyelopathy. A review and a study of two families. Brain. 1971;94:1-30.

Rahman S. Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996;39:343-51.

Chae JH, Lee JS, Kim KJ, Hwang YS, Hirano M. Biochemical and genetic analysis of Leigh syndrome patients in Korea. Brain Dev. 2008;30:387-90.

Arii J, Tanabe Y. Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol. 2000;21:1502-9.

Chi CS, Mak SC, Shian WJ, Chen CH. Oral glucose lactate stimulation test inmitochondrial disease. Pediatr Neurol. 1992;8:445-9.

Chi CS, Lee HF, Tsai CR, Chen WS, Tung JN, Hung HC. Lactate peak on brain MRS in children with syndromic mitochondrial diseases. J Chin Med Assoc. 2011;74:305-9.

Bianchi MC, Tosetti M, Battini R, Manca ML, Mancuso M, Cioni G, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neuroradiol. 2003;24:1958-66.

Chi CS. Diagnostic approach in infants and children with mitochondrial diseases. Pediatr Neonatol. 2015;56:7-18.

Tsai JD, Liu CS, Tsao TF, Sheu JN. A novel mitochondrial DNA 8597T>C mutation of Leigh syndrome: report of one case. Pediatr Neonatol. 2012;53:60-2.

Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol. 2008;39:223-35.

Medina L, Chi TL, DeVivo DC, Hilal SK. MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect. AJR Am J Roentgenol. 1990;154:1269-74.

Finsterer J, Eichberger H, Jarius C. Lactate-stress testing in 54 patients with mitochondriopathy. Eur Arch Psychiatry Clin Neurosci. 2000;250:36-9.

Finsterer J, Milvay E. Lactate stress testing in 155 patients with mitochondriopathy. Can J Neurol Sci. 2002;29:49-51.

Finsterer J, Shorny S, Capek J, Cerny-Zacharias C, Pelzl B, Messner R, et al. Lactate stress test in the diagnosis of mitochondrial myopathy. J Neurol Sci. 1998;159:176-80.

Sijens PE, Smit GP, Rödiger LA, van Spronsen FJ, Oudkerk M, Rodenburg RJ, et al. MR spectroscopy of the brain in Leigh syndrome. Brain Dev. 2008;30(9):579-83.

Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8:396-413.

Lin DD, Crawford TO, Barker PB. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol. 2003;24:33-41.

Ronchi D, Bordoni A, Cosi A, Rizzuti M, Fassone E, Di Fonzo A, et al. Unusual adult-onset Leigh syndrome presentation due to the mitochondrial m.9176T>C mutation. Biochem Biophys Res Commun. 2011;412:245-8.